Canada's aluminium industry finds unfair and highly disruptive the 25% tariffs announced by the US administration. "A 25% ...
Aging itself is the single greatest risk factor for the majority of these ... began with its use of an adeno-associated virus (AAV) vector. The company’s lead gene therapy, BV-702, is AAV ...
The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...
Marvell Technology's collaboration with Amazon's AWS on Trainium chips boosts its AI infrastructure potential. Find out why ...
In 2019, U of T recognized that solving big, global challenges required a new approach – one that brings together brilliant ...
But openness can also amplify risks. Unrestricted access to AI models increases the potential for misuse, such as for new ...
The biggest breakthroughs come when researchers follow their instincts, ignore conventional thinking and allow themselves to ...
Daily Caller on MSN2h
EXCLUSIVE: Owner Of US Defense Contractor Making Fighter Jet, Missile Parts Listed As Chinese Intel Agency OfficialA defense contractor that supplies parts for American military aircraft and advises the U.S. government on supply chain ...
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback